You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.

Treatment of Bipolar Disorder and Cocaine Use Disorder in the Black Community


Compared to other psychiatric disorders, bipolar disorder is associated with increased risk of substance abuse.  Cocaine use is a particular risk for people with bipolar disorder because cocaine is tied to the putative underlying neurochemistry of bipolar disorder.  Cocaine use disorder adds additional complexity to the treatment of bipolar disorder. Another complicating factor is that bipolar disorder is associated with increased risk of stimulant abuse.  This webinar will discuss the challenges of treating cocaine use disorder among African Americans with bipolar disorder given the history of misdiagnosis of bipolar disorder and the high prevalence of stimulant abuse in the Black community.


  1. Describe the special impact of misdiagnosis and under recognition of bipolar disorder especially in African Americans.
  2. Discuss how bipolar disorder increases the risk for cocaine use and abuse.
  3. Explain how the putative neurochemistry of bipolar disorder intersects with the pharmacology of cocaine use.
  4. List how the treatment of cocaine dependence is complicated in bipolar disorder.


Psychiatrists, psychologists, social workers, nurse specialists, drug abuse counselors, individuals with lived experiences


William B. Lawson, MD, PhD, DLFAPA


Dr. Lawson is the Founder and Director of the Institute for Reducing Disparities, LLC, President of Senior Psychiatrists Inc, Director of Psychiatric Research for the Emerson Clinical Research Institute, and Professor of Psychiatry and Behavioral Sciences at the George Washington University and the University of Maryland School of Medicine. He is an emeritus professor of psychiatry at Dell Medical School, University of Texas, Austin, and an emeritus professor and former chair of psychiatry and behavioral sciences at Howard University School of Medicine. He received a Ph.D. in Psychology from the University of New Hampshire and an MD from the Pritzker School of Medicine, University of Chicago. He completed his residency at Stanford University and a fellowship at the National Institute of Mental Health. He is and has held faculty positions at the University of Illinois, Urbana, University of California, Irvine, Vanderbilt University, University of Arkansas, and Howard University. He has held numerous senior positions and received national recognition including past President of the DC chapter of Mental Health America, Past President of the Washington Psychiatric Society, past Chair of the Psychiatry and Behavioral Sciences of the Section of the National Medical Association, and past president of the Black Psychiatrists of America.

Dr. Lawson received the American Psychiatric Foundation Award for Advancing Minority Mental Health, the Solomon Carter Fuller Award by the American Psychiatric Association, the Sigma XI scientific honor society and Alpha Omega Alpha, the medical honor society, the National Alliance for the Mentally Ill Exemplary Psychiatrist Award and Outstanding Psychologist Award, the Jeanne Spurlock Award from the American Psychiatric Association, the E.Y. Williams Clinical Scholar of Distinction Award from the NMA, and the George Winokur Clinical Research Award from the American Academy of Clinical Psychiatrists. He has more than 200 publications and is a former editor-in-chief of the Journal of the National Medical Association. He has continuously received federal, industry, and foundation funding to address mental and substance abuse disparities. Dr. Lawson currently serves as the President of the Senior Psychiatrists, Inc. of the American Psychiatric Association.





Starts: Oct. 20, 2022 12:00 pm
Ends: Oct. 20, 2022 1:00 pm
Registration Deadline
October 13, 2022
Event Type
Webinar/Virtual Training
Hosted by
Contact Us for More Info